Medanta Expands Indore Presence with Acquisition of 80-Bed Cancer Hospital
Global Health Limited 'Medanta', a leading multispecialty tertiary care provider operating across North and East India, has announced a strategic expansion in Indore, Madhya Pradesh. The company plans to take over an 80-bedded Cancer Hospital through a Business Transfer Agreement (BTA).This acquisition is designed to significantly strengthen Medanta’s presence in Central India and complement its existing 175-bedded multi-specialty facility.
Under the terms of the Business Transfer Agreement, Asian Institute of Oncology Private Limited, acting as the transferor, will transfer the Indore Business Undertaking (AIOPL Indore) as a going concern to Medanta, the transferee. Medanta will pay a consideration of Rs. 30 crores for the transfer of this business, which includes the assignment of the long-term lease.
The newly acquired Cancer Care Hospital is strategically situated just 500 meters from the current Medanta Indore facility. The integration of this specialized oncology unit is expected to allow Medanta to launch a comprehensive oncology program, enhancing its specialty offerings in the city. Industry observers note that the integration is set to drive operational synergies, optimize capacity utilization, and improve patient flow across both facilities.
Pankaj Sahni, Group CEO of Medanta, stated that the takeover represents a major extension of the company's existing operations in Indore. He added that the state-of-the-art oncology infrastructure provides comprehensive cancer care, which was previously a missing specialty, thereby enhancing patient access and reinforcing Medanta's position as a key provider of specialized, high-quality care in the region.
Company Profile: Global Health Limited (Medanta)
Global Health Limited, founded by Dr. Naresh Trehan, a recipient of the Padma Bhushan and Padma Shri, is recognized as one of the largest private multi-specialty tertiary care providers in the North and East regions of India. The company provides healthcare services across more than 30 medical specialties.According to a report by CRISIL Limited, Global Health Limited's core specialties include cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology.
The company operates under the 'Medanta' brand and maintains a vast operational network:
| Metric | Detail |
|---|---|
| Operational Hospitals | 6 (Gurgaon, Indore, Ranchi, Lucknow, Patna, Noida) |
| Total Installed Beds (as of Dec 31, 2025) | 3,579 beds |
| Total Area Spanned | 5.6 million sq. ft. |
| Doctors Engaged | Over 2,300+ doctors |
| Upcoming Hospitals | Mumbai, Guwahati, Varanasi, and two in Delhi |
MEDANTA Stock Price Movement
Shares of Global Health Limited are edging higher in live trading, gaining 5.26% as of 3:26 PM today, currently trading at ₹1163.7. The stock shows significant investor interest, with 160,612 shares traded throughout the volatile session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.